Home|Journals|Articles by Year|Audio Abstracts
 

Letter to the Editor



Low dose indomethacin for symptomatic treatment of COVID-19

Ravichandran Rajan, Srinivasan Subramanian, Chritine Clark.




Abstract
Cited by 6 Articles

At present paracetamol is widely used for symptomatic treatment in Covid-19 with poor results. Indomethacin is a powerful anti inflammatory drug and gives relief in low doses also. We describe our experience in using indomethacin in a small number of patients with Covid-19 including those who would be classied as high risk. The response to indomethacin is rapid and would help reducing hospitalisation during the epidemic.

Key words: Indomethacin, Covid-19, Symptoms






Full-text options


Share this Article


Online Article Submission
• ejmanager.com


ejPort - eJManager.com
Refer & Earn
JournalList
 About BiblioMed
License Information
Terms & Conditions
Privacy Policy
 Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.